Details

Autor(en) / Beteiligte

• Atmar, Robert L
• Lyke, Kirsten E
• Deming, Meagan E
• Jackson, Lisa A
• Branche, Angela R
• El Sahly, Hana M
• Rostad, Christina A
• Martin, Judith M
• Johnston, Christine
• Rupp, Richard E
• Mulligan, Mark J
• Brady, Rebecca C
• Frenck, Robert W
• Bäcker, Martín
• Kottkamp, Angelica C
• Babu, Tara M
• Rajakumar, Kumaravel
• Edupuganti, Srilatha
• Dobrzynski, David
• Coler, Rhea N
• Posavad, Christine M
• Archer, Janet I
• Crandon, Sonja
• Nayak, Seema U
• Szydlo, Daniel
• Zemanek, Jillian A
• Dominguez Islas, Clara P
• Brown, Elizabeth R
• Suthar, Mehul S
• McElrath, M. Juliana
• McDermott, Adrian B
• O’Connell, Sarah E
• Montefiori, David C
• Eaton, Amanda
• Neuzil, Kathleen M
• Stephens, David S
• Roberts, Paul C
• Beigel, John H

Titel

Homologous and Heterologous Covid-19 Booster Vaccinations

Ist Teil von

• The New England journal of medicine, 2022-03, Vol.386 (11), p.1046-1057

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2022

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Participants who had been fully vaccinated with current Covid-19 vaccines received homologous or heterologous boosters, and their immune response was measured on days 15 and 29. Homologous boosters increased neutralizing antibody titers by a factor of 4 to 20, whereas heterologous boosters increased titers by a factor of 6 to 73.